罗关联酶调节兰格汉斯细胞形态和对组织损伤的反应能力
Eric Peterman1, Elgene J A Quitevis1, Camille E A Goo1
1Department of Biology, University of Washington, Seattle, WA 98195, USA.
Cell reports
|May 10, 2024
概括
斑马鱼皮肤中的朗格汉斯细胞使用动态树突来清除碎片. 动蛋白和ROCK通路在组织修复过程中调节它们的形状,运动和碎片清除.
科学领域:
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
- 细胞生物学 细胞生物学
背景情况:
- 皮肤损伤需要免疫细胞的反应来修复器官.
- 朗格汉斯细胞,表皮免疫细胞,使用树突突突出监视皮肤.
- 朗格汉斯细胞状动态和组织损伤反应的机制尚不清楚.
研究的目的:
- 为了研究兰格汉斯细胞树动力学和碎片清除机制,以应对皮肤损伤.
- 阐明了在朗格汉斯细胞功能中的actin细胞骨架和Rho相关激酶 (ROCK) 途径的作用.
主要方法:
- 使用成年斑马鱼皮肤扩展剂进行体内观察.
- 应用了动因抑制剂和ROCK抑制剂来研究细胞反应.
- 观察了朗格汉斯细胞形态,树动力学和迁移模式.
主要成果:
- 朗格汉斯细胞在轴突退化后保持监视,并用树突来吞轴突碎片.
- 形状从分支变为圆形的转变使得更大的角质细胞碎片被吞没.
- 乙在树突中存在;ROCK抑制导致树突延长,碎片清除受损,并减少到伤口的迁移.
结论:
- 朗格汉斯细胞状体的动态对于清除轴突和状细胞残骸至关重要.
- ROCK通路在调节朗格汉斯细胞形态,迁移和对皮肤损伤的免疫反应方面发挥着重要作用.
更多相关视频
06:56Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases
Published on: September 6, 2024
358
10:16SorLA and CLC:CLF-1-dependent Downregulation of CNTFRα as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry
Published on: January 6, 2017
7.3K
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
MAPK Signaling Cascades
5.4K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.4K
Receptor Tyrosine Kinases
12.8K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
12.8K
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Small GTPases - Ras and Rho
3.9K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
3.9K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
